Human Genome starts shipping new anthrax drug
WASHINGTON (Reuters) - Human Genome Sciences Inc. said on Monday it was beginning delivery of 20,000 doses of ABthrax, which fights anthrax infection, to the U.S. government.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~f/reuters/healthNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=ik3AF6JR) <img src="http://feeds2.feedburner.com/~f/reuters/healthNews?i=tk9PEhHE" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=tk9PEhHE) <img src="http://feeds2.feedburner.com/~f/reuters/healthNews?i=LntYkBXu" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=LntYkBXu)
</div><img src="http://feeds2.feedburner.com/~r/reuters/healthNews/~4/FoFD777_AzI" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/FoFD777_AzI/idUSTRE5112C220090202